81
Participants
Start Date
August 1, 2019
Primary Completion Date
February 29, 2020
Study Completion Date
March 1, 2020
Dexmedetomidine
Dexmedetomidine (DEX) a potent α 2 agonist that have unique analgesic, anxiolytic and sedative profile has been called upon as attractive adjunct in general as well as regional anesthesia with enticing results. Several studies have pursued DEX median effective dose (ED50) in different settings e.g., co induction agent with Propofol, in laryngeal muscle insertion and with local anesthetic to enhance the quality of spinal anesthesia
South Valley University, Qina
Tanta University
OTHER
South Valley University
OTHER